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Necrotizing Enterocolitis
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Abstract
Necrotizing enterocolitis (NEC) is the commonest inflammatory gastrointes-
tinal disorder of newborn infants, occurring primarily in premature neonates. 
Presenting as a medical and surgical emergency, it is associated with significant 
morbidity and mortality. NEC is characterized by acute intestinal inflammation 
and necrosis with intramural dissection of gas, pathognomically appearing as 
pneumatosis intestinalis on radiography. The incidence and mortality, with an 
inverse relationship to maturation, range between 3–11% and 17–20% respec-
tively. Mortality may be up to 50% in extremely premature infants who require 
surgery for intestinal perforation or gangrene. The exact etiopathogenesis is 
unknown. Over 90% of infants are premature and more than 98% are enterally 
fed. NEC presents with feeding intolerance and abdominal distension, which 
may rapidly progress to cardiorespiratory decompensation and death in severe 
cases. Intestinal dysbiosis and its functional and immunological immaturity are 
proposed to play roles in the pathogenesis. While exact triggers are undetermined, 
the disease is marked by an anomalous immunological response of enterocytes 
to inflammation, invoking cytokines and chemokines. NEC is treated with bowel 
rest, antibiotics, cardiorespiratory support, parenteral nutrition, and blood prod-
ucts transfusion. Approximately 30% of cases require surgery and a significant 
number of survivors suffer from neurological deficits, intestinal dysfunction, and 
post surgical short bowel syndrome.
Keywords: necrotizing enterocolitis, preterm infants, pneumatosis intestinalis, 
intestinal gangrene, intestinal perforation, intestinal dysbiosis, short bowel 
syndrome, feeding intolerance, heme positive stools, abdominal distension, 
cardiovascular decompensation
1. Introduction
Necrotizing enterocolitis (NEC) is an acquired, multifactorial and devastating 
gastrointestinal disease associated with high morbidity and mortality in preterm 
neonates. With an incidence of about 7% in infants with BW < 1500 g and mortality 
up to 30%, NEC presents as a medical and surgical emergency [1, 2]. It is charac-
terized by ischemia, necrosis, and inflammation of bowel wall with invasion by 
gas-forming organisms and intramural dissection of gas, characteristically appear-
ing as pneumatosis intestinalis in radiological and pathological studies. While exact 
etiology is undetermined, the pathogenesis is believed to be an anomalous innate 
immune response to an altered, less diverse intestinal microbiota by the highly 
immunoreactive enterocytes of premature infants, leading to inflammation and 
tissue necrosis [3, 4]. The clinical presentation can be severe with cardiorespiratory 
collapse, shock, and disseminated intravascular coagulopathy (DIC), escalating 
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to multisystem failure and death [2]. About one third of the cases require surgical 
intervention due to intestinal perforation and gangrene [5]. NEC is the commonest 
gastrointestinal (GI) disorder of preterm newborn infants, although term infants 
can be affected. NEC is associated with significant adverse outcomes, and approxi-
mately half of the survivors suffer from abnormal neurodevelopment independent 
of maturational status at birth. It is one of the most important causes of intestinal 
failure in children. Despite substantial advances in its diagnosis, prevention, and 
management strategies, the incidence has not changed, especially in very low birth 
weight neonates, and the morbidity and mortality associated with necrotizing 
enterocolitis continue to be high.
2. Epidemiology
NEC constitutes about 2–5% of all NICU admissions. The incidence reported 
in 2012 by the Canadian Neonatal Network (CNN) in infants less than 33 weeks of 
gestational age (GA) was 5.1% [1]. In the United States the incidence is estimated 
to be 1–3 per 1000 live births [2, 6], while its prevalence is 0.3–2.4 per 1000 live 
births. There is considerable variability in incidence among different geographical 
locations and neonatal intensive care units [6–8]. Henry and Moss noted an overall 
incidence of 3–7% in 2005 [5]. A review by the National Institute of Child Health 
and Human Development (NICHD) Neonatal Research Network data from 1998 
to 2001 reported a 7% incidence of NEC among very low birth weight infants [9], 
while a more recent report from the network in 2010 documented an incidence of 
11–15% in neonates < 1500 g or < 32 weeks at birth [10]. The incidence was found 
to be relatively unchanged at approximately 7% in infants weighing <1500 g in 
another report published in 2011 [11]. Ninety percent of the infants are preterm 
and the rest term or late preterm. Incidence and mortality are inversely related to 
GA and birth weight (BW). Mortality in preterm infants from NEC may be up to 
30–50%, and 27% of infants require surgical intervention with an overall case fatal-
ity rate of 15% [5, 11, 12]. The mortality rate is higher in surgical NEC and African 
American males [13]. Forty-six percent of survivors suffer from abnormal neurode-
velopment, and 12% of all cases of GI failure in children are due to NEC [14]. The 
risk and mortality associated with NEC were stratified according to BW and GA in 
a cohort of extremely premature infants in who the overall incidence was estimated 
to be 7.5% (Tables 1 and 2) [2].
Despite the variability in incidence among studies with rates ranging between 
3 and 15% in VLBW infants, a relative stability in the incidence over time has 
been noted. Survival in NEC has not changed in the past five decades, the average 
mortality being 20–30% and up to 50% in infants requiring surgical management 
[10]. The proportion of neonates with NEC requiring surgical intervention has 
Table 1. 
Risk and mortality associated with NEC based on birth weight.
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also remained stable at approximately 30% [15]. The reasons for such observa-
tions are the decreasing gestational age limit for neonatal viability and increased 
survival of extremely premature infants with advances in neonatal care. Practice 
implementations, such as standardizing enteral feeding guidelines, exclusive 
feedings of own mother’s milk, using donor breast milk when mother’s milk is 
not available, minimizing duration of empiric antibiotics after birth, and avoid-
ing packed red blood cells (PRBC) transfusions as well as antacid use in preterm 
infants, are associated with a decrease in incidence of NEC in very low birth 
weight infants [16].
3. Etiology and risk factors
The exact etiology of NEC is undetermined and multiple risk factors have 
been forwarded. NEC occurs in a stereotypic relation at chronological age of 
onset to the gestational age at birth, the younger the gestation, the later the onset; 
and requires that the infant be fed [1, 11]. In one study the median age at onset 
in infants with a GA of less than 26 weeks was 23 days compared to a median 
age of 11 days for more mature infants with a GA of greater than 31 weeks [17]. 
Prematurity is the single greatest risk factor with almost 90% patients being 
premature. Enteral feeding is the second most common feature with over 98% of 
cases having a history of feeding. However, rate of advancement unless excessive, 
trophic, and early versus late and colostrum feeding are not conclusively proven 
to have any effect on the occurrence of NEC [18]. Other suggested risk factors 
are the 5 min Apgar score < 7, outborn status, body temperature 0f 36°C at 1 h 
of age, cesarean section, use of indomethacin with or without dexamethasone, 
sepsis, use of inotropes, severe metabolic acidosis, patent ductus arteriosus 
(PDA), gastroschisis, severe anemia, polycythemia, packed red blood cell (PRBC) 
transfusion, use of H2 antagonist, exposure to empirical antimicrobials, and black 
and Hispanic ethnicity [19]. Approximately 10% of cases occur in term and late 
preterm infants. Risk factors for NEC in term infants are nonhuman milk feeding; 
preexisting illnesses, such as congenital heart disease; primary gastrointestinal 
disorders; sepsis; polycythemia; respiratory disease; hypotension; neonatal 
Table 2. 
Risk of NEC based on gestational age.
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abstinence; fetal growth restriction; and perinatal hypoxia [20]. Despite the fact 
that no predilection for sex, race, or ethnicity has been conclusively established, a 
higher incidence is observed in male African American infants than in any other 
single demographic. This could be related to the higher incidence of prematurity 
in this ethnic group than in the general US population. Hypoxic ischemic injury 
is no longer considered a major predisposing factor in the development of NEC 
except in term babies [21].
4. Pathology
NEC primarily affects the ileum and colon, the commonest location being 
ileocecal area [22]. The entire gastrointestinal tract may be involved in severe 
cases. On gross examination, the bowel loops are distended with areas of hem-
orrhage, congestion, necrosis, and pneumatosis (Figure 1). On microscopic 
examination, signs of inflammation, mucosal edema, bacterial invasion, sub-
mucosal and intramural gas bubbles, and ischemic transmural necrosis are seen. 
Intestinal perforation may happen when the entire thickness of bowel is involved 
leading to pneumoperitoneum, peritonitis, and portal venous gas (Figure 2). 
Microscopically, the predominant feature is coagulation necrosis, suggesting 
an ischemic origin of NEC. The aggregated inflammatory cells are both acute 
and chronic, such as neutrophils, lymphocytes, and macrophages representing 
an appropriate response to pathogenic bacterial invasion and tissue necrosis. 
Epithelial regeneration, granulation tissue formation and fibrosis may be seen 
suggesting reparative histological process [23]. Common pathogens isolated in 
NEC are Enterobacteriaceae including Escherichia, Salmonella, Enterobacter, and 
Klebsiella (68%); staphylococcal species (26%); clostridium species (4%); viruses 
including rota, echo, corona, and toro (11%); and candida (1%). No organism is 
isolated in 3% of cases.
Figure 1. 
Macroscopic appearance of necrotizing enterocolitis showing necrotic bowel loops. [Courtesy of Renu Sharma, 
MD, Professor of Pediatrics, University of Florida at Jacksonville, USA].
5Necrotizing Enterocolitis
DOI: http://dx.doi.org/10.5772/intechopen.85784
5. Pathogenesis
The pathogenesis of NEC is complex, multifactorial, and incompletely defined. 
The disorder is believed to be a composite result of intestinal immaturity, aber-
rant immunological response, and gut microbial dysbiosis [3, 4, 23, 24]. It almost 
never occurs when the intestinal immune system is mature and intact, even when 
other risk factors are present. Experimental NEC does not occur in sterile environ-
ment. Research support the hypothesis that NEC in the preterm infant results from 
a multifactorial process that requires the concurrent presence of an immature 
intestinal tract and immune system leading to increased susceptibility, factors 
causing disruption of the normal intestinal bacterial microbiome with growth of 
potentially pathogenic bacteria, and an exaggerated inflammatory host response 
with the release of cytokines and chemokines (Figure 2). A genetically determined 
predisposition to necrotizing enterocolitis has been also proposed implying the 
contribution of genetic polymorphisms in the pro-inflammatory cytokines associ-
ated with NEC [25]. The combination of compromised intestinal epithelial barrier; 
underdeveloped and anomalous immune defense; abnormal mesenteric vascular 
development, tone, and flow; and altered luminal microbiota shaped by formula 
feedings, antibiotic exposure, and cesarean delivery presumably leads to intestinal 
inflammation and gangrene. NEC is triggered when several risk factors heighten 
neonatal intestinal inflammation and an irreversible borderline is surpassed.
5.1 Intestinal immaturity, dysbiosis, and barrier dysfunction
Immaturity of neonatal intestinal mucosal barrier and mucosal immune system 
is characterized by decreased mucus coat, altered mucus protein, reduced Ig A, and 
abnormal epithelial membrane and tight junctions [4, 26, 27]. Preterm intestinal 
Figure 2. 
Schematic presentation of pathogenesis of NEC.
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mucosa is highly immunoreactive, and fetal human enterocytes have been shown to 
evoke excessive immunological and inflammatory response compared to adults. An 
imbalance between epithelial cell injury and repair leads to a gut barrier failure and 
a consequent cycle of bacterial invasion, immune activation, uncontrolled inflam-
mation, and gut necrosis (Figure 2).
5.2 Feeding and immature GI function
Premature GIT is relatively deficient in digestive functions and peristaltic 
motility in addition to immune responses [28]. Dysfunctional gastric emptying 
and increased gastric pH add to gut barrier disruption and epithelial permeability 
[4, 29–31]. Aggressive feeding with peristaltic dysmotility leads to stasis of intra-
luminal contents and intestinal dilatation, which may further impair epithelial 
barrier (EB). These, in concurrence with microbial dysbiosis, result in abnormal 
signal transduction across the EB with consequent inflammation, apoptosis, and 
necrosis. The balance between the pro-inflammatory and anti-inflammatory sig-
naling is affected with an inappropriate response to pathogenic microorganisms.
5.3 Role of cytokines and chemokines
NEC is associated with increased expression of inflammatory cytokines, such 
as tumor necrosis factor (TNF), interleukin (IL)-1β, IL-6, IL-8/CXC-motif ligand 
8 (CXCL8), IL 10 monocyte chemoattractant protein-1/CC-motif ligand (CCL)-2, 
macrophage inflammatory protein-1β/CCL3, and C-reactive protein in plasma and 
affected tissues [32]. These cytokines can disrupt the epithelial barrier and aug-
ment intestinal injury. Serum levels of cytokines/chemokines are elevated in NEC, 
and increased TLR4 and abnormal IkB/NFkB suggest excessive abnormal immu-
nological response [33–35]. Lower blood TGF-β and interleukin (IL)-2 and higher 
IL-8 levels are found in ELBW infants with NEC. A developmental immaturity is 
noted in IkB expression, the molecule that inhibits cytokines activation via NFkB 
in NEC. Recently the role of toll-like receptor 4 (TLR4) signaling in the pathogen-
esis of NEC has been highlighted. Hypoxia, infection, and prematurity accentuate 
the expression of TLR4 in the intestinal mucosa. TLR4 is subsequently activated 
by enteric bacteria, triggering an inflammatory cascade which results in increased 
gut mucosal injury and reduced epithelial repair. Activation of cytoplasmic innate 
immune receptors, NOD2 and TLR9 leads to inhibition of TLR4, with restoration 
of the intestinal epithelial barrier and reduction in severity of NEC in experimen-
tal models. Other factors implicated in pathogenesis of NEC are platelet-activating 
factor, nitric oxide, reactive oxygen species, and transforming growth factors. 
However, despite success in animal model systems, no significant improvement in 
treatment and outcomes of NEC has been achieved due to an incomplete under-
standing of the developing immune system in premature infants and inability to 
replicate them in animal models [32].
6. Clinical presentation
NEC presents acutely with feeding intolerance, heme-positive stools, abdomi-
nal distension, gastric residuals, and vomiting in a previously stable and feeding 
preterm infant. Commonly associated nonspecific symptoms are temperature 
instability, apnea, bradycardia, oxygen desaturation, and lethargy. There may 
be abdominal wall erythema, abdominal tenderness, and decreased or absent 
bowel sounds (Figure 3). As the disease process advances, cardiorespiratory 
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decompensation, septic shock, and multi-organ failure may supervene. The 
diagnosis is confirmed by the presence of pneumatosis intestinalis in abdominal 
X-ray which is pathognomonic of NEC (Figure 4). The course may be mild to 
moderate with recovery with antibiotics, GI rest, and correction of biochemical 
and hematological anomalies, or fulminant with early signs of severe systemic 
Figure 3. 
Abdominal distension, erythema and skin ulceration in a case of necrotizing enterocolitis. [Courtesy of Renu 
Sharma, MD, Professor of Pediatrics, University of Florida at Jacksonville, USA].
Figure 4. 
Extensive pneumatosis with branching linear lucencies in the liver, consistent with portal venous gas. [Courtesy 
of Dr. Renu Aggarwal, Attending Neonatologist, NYU Winthrop Hospital, Mineola, NY, USA].
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Table 3. 
Modified Bell’s staging criteria for necrotizing enterocolitis in neonates [33].
inflammatory response and poor response to correction of metabolic and hemato-
logical derangements, such as severe metabolic acidosis, hyponatremia, hypergly-
cemia, thrombocytopenia, DIC, anemia, and neutropenia, eventually progressing 
to death.
Age of onset varies in an inverse relationship with GA at birth, and the average 
post menstrual gestational age of NEC is estimated to be 31–32 weeks. In a cohort 
of preterm infants under 33 weeks gestational age, NEC presented at a mean of 
7 days in more mature infants, while it was delayed to 32 days in lower birth weight 
and gestational age neonates [1]. The average age of onset has been reported to be 
20.2 days for babies born at less than 30 weeks’ estimated gestational age, 13.8 days 
for babies born at 31–33 weeks, and 5.4 days for babies born after 34 weeks of gesta-
tion. Term infants develop necrotizing enterocolitis much earlier, with the average 
age of onset within the first week or within the first 1–2 days of life [36].
To classify the severity of NEC based on clinical findings, a staging criterion was 
proposed by Bell in 1978 which was later modified (Table 3) [37]. In about one third of 
cases, NEC is suspected but not confirmed (stage I), and symptoms resolve gradually 
with treatment. In 25–40% of cases, the progression of NEC is fulminant with signs of 
peritonitis and sepsis and the rapid development of DIC and shock (stage III). About 
30% of the cases may develop intestinal perforation, peritonitis, and other complica-
tions necessitating surgical intervention. Mean LOS is 62 days in surgical and 36 days 
in medical NEC cases [15]. Surgical NEC cases incur higher hospital costs.
7. Laboratory and radiological investigations
In all cases of NEC, CBC with diff, blood culture, C-reactive protein, 
serum electrolytes, pH, lactate, acid-base indicators, arterial blood gases, 
9Necrotizing Enterocolitis
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and pertinent radiography should be done. The characteristic anomalies are 
metabolic or mixed acidosis, high C-reactive protein (CRP), hyponatremia, 
hyperglycemia, thrombocytopenia, neutropenia, or leukocytosis with high 
I/T ratio. CSF studies are suggested, and peritoneal fluid analysis for bacteria 
and fecal material should be done if paracentesis abdominis is performed for 
therapeutic or diagnostic purposes. Presentation of NEC is similar to, or may 
be associated with sepsis, and the differentiation is confirmed by the presence 
of pneumatosis intestinalis (PI) on radiography (Figure 5). Apart from PI 
other radiological features of NEC are ileus, bowel wall thickness, and bowel 
perforation with peritoneal air. Bowel wall thickening, with or without echo-
genicity, indicates increasing inflammation, swelling, and perfusion of the area. 
Bowel loops may be separated by the presence of peritoneal fluid and give an 
impression of thickening. Thin bowel wall with a central echogenic focus and 
a hypoechoic rim, called pseudo-kidney sign, if present, may indicate necrotic 
bowel and imminent perforation. Ultrasound detection of small air bubbles 
in the bowel wall as in pneumatosis intestinalis can be spatially differentiated 
from air bubbles in stool that can sometimes be misdiagnosed as pneumatosis 
on radiographs. Ultrasonography also can detect intermittent gas bubbles in the 
liver parenchyma and portal venous system that are not detected on radiography. 
Ultrasound is more sensitive in detecting peritoneal fluid collections. Doppler 
ultrasound is dynamic and permits real-time visualization of bowel wall thick-
ness, peristalsis, and perfusion. It is more sensitive than abdominal radiography 
in detecting bowel necrosis [15]. Evidence of free peritoneal air and ascites 
indicate intestinal perforation. Contrast enemas are not recommended if NEC 
is suspected, as it may result in bowel perforation with extravasation of contrast 
material into the peritoneum. Near-infrared spectroscopy (NIRS) is a new, 
noninvasive method of estimating local tissue hemoglobin oxygen saturation by 
measuring the difference between oxyhemoglobin and deoxyhemoglobin and 
may have utility in diagnosing intestinal ischemia in NEC. Fortune et al. demon-
strated cerebro-splanchnic oxygenation ratio < 0.75 to have a positive predictive 
value of 0.75 for intestinal ischemia, whereas, if above 0.75, intestinal ischemia 
is excluded with a negative predictive value of 0.96 [38].
Figure 5. 
On left: massive pneumoperitoneum with visualization of falciform ligament, massive lucency involving the 
entire abdomen, visualization of the liver margin. On right: left lateral decubitus radiograph demonstrating 
massive lucency with visualization of the liver margin and bowel. [Courtesy of Dr. Renu Aggarwal, Attending  
Neonatologist, NYU Winthrop Hospital, Mineola, NY, USA].
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7.1 Differentiating medical and surgical NEC: use of biomarkers
Pneumoperitoneum is not a very reliable clinical feature for surgical NEC and is 
observed in less than half of all infants with intestinal perforation or necrosis  
[15, 39]. Clinical deterioration despite maximal medical therapy is considered a rela-
tive indication for surgical intervention. Research has been done to identify a depend-
able predictor for intestinal necrosis. The most commonly used biochemical markers 
for bowel necrosis among pediatric surgeons are platelet count (99%), C-reactive pro-
tein (CRP) concentration (90%), white blood cell count (83%), lactate levels (43%), 
fecal calprotectin 10%, and interleukin (IL)-6 or interleukin-8 10% [40]. Fecal cal-
protectin is a marker of intestinal inflammation and can differentiate between local 
Bell stage II and systemic Bell III NEC with 76% sensitivity and 92% specificity [41]. 
Fecal levels of another protein, S100A12, are noted to be higher in infants with sus-
pected NEC who subsequently develop bowel perforation. Unremitting and relent-
lessly high CRP levels despite treatment may indicate advanced stage of NEC and 
bowel necrosis. IL-8 levels have been shown to be significantly elevated in patients 
developing surgical NEC compared to medically managed NEC [42]. The levels can 
also discriminate NEC totalis from focal and multifocal diseases and predict 60-day 
mortality [43]. Maximum concentration of CRP and duration of CRP elevation are 
increased in infants who developed intestinal strictures following NEC, while the 
negative predictive value of CRP levels <10 mg/dL for stricture development is 100% 
[44]. Intestinal fatty acid-binding protein (I-FABP), a marker of intestinal injury and 
progression to severe NEC, is located in mature enterocytes of small intestinal villi 
and is released into the blood stream after cell disruption and subsequently excreted 
into the urine. At onset of symptoms, I-FABP concentrations have been shown to be 
significantly higher in infants who later developed surgical NEC [45]. Other bio-
markers being investigated for surgical NEC are serum amyloid A protein, liver fatty 
acid-binding protein, urine peptides, and heart rate characteristic index.
8. Differential diagnosis
Blood stream infection can present like NEC and must be ruled out. Sepsis and 
other conditions that can cause feeding intolerance, rectal bleeding, abdominal 
distension, gastric retention of feed, or intestinal perforation can be differentiated 
from NEC by the absence of radiologic evidence of pneumatosis intestinalis and the 
characteristic combination of rectal bleeding presenting as heme-positive or grossly 
bloody stools, abdominal distention, bilious vomiting, and gastric aspirates as seen 
in NEC. Spontaneous intestinal perforation is characterized by a single noninflam-
matory perforation that is typically located at the terminal ileum or colon. It occurs 
primarily in infants with birth weight <1000 g and is differentiated from NEC by 
the presence of less severe systemic signs and absence of pneumatosis intestinalis. 
Infectious enteritis may present with frequent, occasionally bloody stools with 
abdominal distension but no pneumatosis. Congenital anomalies of GIT, such as 
Hirschsprung disease, small bowel atresia, meconium ileus, and acquired condi-
tions like volvulus and intussusception, present with intestinal obstruction and at 
times secondary enterocolitis. Abdominal radiography differentiates these condi-
tions from NEC. Anal fissures can result in rectal bleeding and can be detected on 
pertinent thorough physical examination. Milk protein allergy-induced enterocoli-
tis may present with heme-positive stools and other GI symptoms similar to NEC in 
preterm infants but no pneumatosis. Such patients respond to dietary modification 
by switching the formula to extensively hydrolyzed or amino acid-based ones and 
may have eosinophilia along with thrombocytosis.
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9. Management
The basic principles of management of NEC are bowel decompression and rest, 
antibiotics coverage, cardiorespiratory support, fluid resuscitation, provision of 
blood products, and surgical intervention if indicated. The management strategies 
according to Bell’s staging are outlined in Table 4. Surgical consultation is obtained 
in all stages of NEC including stage 1. Total parenteral nutrition (TPN) should be 
provided during the period that the infant is nil by mouth.
9.1 Medical management
The principles are as follows: (1) bowel decompression and rest, (2) parenteral 
hydration and nutrition, (3) respiratory and cardiovascular support, (4) antibiotic 
therapy, (5) general supportive care, (6) fluid resuscitation, and (7) serial close labora-
tory monitoring and radiologic surveillance. The focus is on limiting the progression 
of the disease. Intermittent or continuous nasogastric suction is done for bowel 
decompression, TPN is provided to ensure nutrition, and fluid is replaced to correct 
third space losses. Adequate cardiorespiratory support is of paramount value, and 
hematologic anomalies, such as DIC, anemia, and thrombocytopenia, are promptly 
corrected. Metabolic abnormalities, such as metabolic acidosis, hyponatremia, and 
hyper- or hypoglycemia, are appropriately treated. Even though an infectious agent has 
not been identified or attributed to NEC, antibiotics are routinely used in its treatment. 
Observational data reveal that 20–30% cases of NEC have bacteremia, and pathogenic 
bacteria are recovered from pathologic specimens and peritoneal fluid. Epidemic 
outbreaks of NEC are common, and the clinical picture improves with antibiotics. 
The efficacy of antibiotic agents is documented in experimental animal models for 
NEC. The commonly used empiric broad-spectrum antibiotic combinations are as 
follows: ampicillin gentamicin (or amikacin), ampicillin, gentamicin (or amikacin) and 
clindamycin or ampicillin, cefotaxime, and metronidazole. Ceftazidime is an alternative 
choice for cefotaxime. Other antibiotic combinations are tazobactam and gentamicin 
(or amikacin); vancomycin, piperacillin-tazobactam, and gentamicin; and merope-
nem and vancomycin if methicillin-resistant staphylococcus or ampicillin-resistant 
enterococcus infections are suspected. Amikacin may be used in centers with significant 
gentamicin resistance. Metronidazole or clindamycin is added to cover anaerobic 
bacteria, especially in cases where infant is fed orally before NEC supervenes.
Evaluation of progression of the disease is important in order to take appropriate 
and timely steps to avoid further damage to the bowel. Serial laboratory monitor-
ing is routinely performed. At diagnosis stool for guaiac test, complete blood and 
differential neutrophil counts, blood culture, CSF study if indicated, C-reactive 
protein, platelet count, serum electrolytes, pH, creatinine, blood urea nitrogen, 
and acid-base studies are obtained and monitored q 12 or 24 h or more frequently 
NEC Bell’s 
stage
Treatment
1a and 1b Antibiotics × 3 days, NPO
2a NPO, antibiotics × 7–10 days
2b NPO, antibiotics × 14 days
3a As in 2b plus, fluid resuscitation, inotropic and ventilator support, blood products
3b As in 3a plus surgery
Table 4. 
Management principles of NEC [65].
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if needed. In addition, arterial blood gas values are measured and repeated every 
4–6–12 h as per the severity of respiratory decompensation. Serial lactate levels are 
helpful in monitoring progression of the necrotic process and assessing systemic 
status. Worsening or persistent metabolic acidosis and persistent hyperglycemia or 
thrombocytopenia are poor prognostic signs. Improvement in metabolic acidosis 
is a positive prognostic sign but may be misleading if blood circulation to the 
necrotic bowel is completely severed and the generated lactic acid cannot enter the 
circulation. Blood in stools is not predictive of resolution or outcome. Radiographic 
monitoring is done with abdominal radiograph performed in supine position during 
the initial phase of illness. A lateral decubitus view is simultaneously obtained 
with the infant’s left side down to visualize the presence of free air over the liver. It 
should be repeated q 6–12 h as per the severity and progression of the disease and 
when improvement is obtained less frequently. In the initial stages q 4–6 h may be 
appropriate and advisable. Supine cross-table lateral view may be done to visual-
ize layering of free air under umbilical area if patient is too sick to move or put in 
a decubitus position (Figure 2). Radiography is discontinued when pneumatosis 
resolves and bowel gas pattern normalizes.
9.2 Surgical management
The only definite indication for surgery is intestinal perforation. Other rela-
tive indications, which are highly suggestive of bowel perforation or necrosis, 
are abdominal mass, fixed dilated bowel loop, positive paracentesis, and severe 
metabolic acidosis that is unresponsive to treatment (Figures 5 and 6) [46]. Signs 
that indicate peritonitis or bowel necrosis are unremitting clinical deterioration, 
worsening or unrelenting metabolic acidosis, and DIC or thrombocytopenia. Signs 
of ascites and intestinal obstruction may be present. Perforation can occur without 
evidence of free air on the radiograph as the timing of study may not coincide with 
the occurrence of perforation and the free air may get absorbed. Likewise, pneuma-
tosis may not be always caught on serial X-rays. Under such conditions other signs 
and clinical judgment should be used to assess the severity and need for surgery. 
As clinical parameters may not be reliable to assess progression to surgical from 
medical NEC, abnormalities in biochemical markers, such as platelet count, CRP, 
WBC count, blood lactate, fecal calprotectin, and serum IL-6 and IL-8 may be used. 
Surgical procedures performed in cases of NEC are exploratory laparotomy with 
resection of the affected intestinal region or primary peritoneal drainage (PPD). 
PPD is preferred as the initial procedure in ELBW infants and is performed in the 
NICU at bedside with analgesia and local anesthesia. Laparotomy is done in an 
operating room under general anesthesia and may require a second surgical proce-
dure for reanastomosis.
In primary peritoneal drainage abdomen is prepped with iodine solution, and 
local anesthesia is administered. Small transverse incision is made at McBurney’s 
point and abdominal wall layers bluntly dissected to enter the peritoneal cavity. A 
rush of air and the presence of meconium are generally encountered. Cultures are 
obtained, and then peritoneal cavity is copiously irrigated with warm saline solu-
tion. Following this Penrose drain is gently threaded into the abdomen and secured. 
The drain site is observed over the subsequent days. When there is no intestinal or 
meconium drainage, the drain is backed out daily until removed. After the return 
of bowel function, a trial of feeding can be started, or the patency of the gastroin-
testinal tract may be determined with a contrast study. In laparotomy the procedure 
includes resection of the affected bowel segment and placement of a proximal enter-
ostomy (usually an ileostomy) and distal mucous fistula. Primary reanastomosis, 
if required, usually is performed 8–12 weeks after the initial procedure, depending 
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upon the infant’s clinical condition. A contrast enema usually is performed before 
the reanastomosis to detect intestinal strictures. If NEC affects only a short seg-
ment of bowel, and the resection is limited, some surgeons perform a primary 
anastomosis. Complications associated with ileostomies are fluid and electrolyte 
abnormalities, delayed resumption of oral feedings, poor growth, and stenosis of 
the enterostomy site. An alternative approach is placement of an intestinal patch 
and peritoneal drain instead of resection and enterostomy. Preservation of ileocecal 
valve is a favorable prognostic sign. When a substantial length of bowel is affected, 
resection is restricted to segments of definite necrosis or perforation to avoid the risk 
of short bowel syndrome. If the potential viability of some segments is uncertain, 
one approach is to place peritoneal drains and plan a second operation in 2–3 days to 
reexamine the bowel and excise necrotic segments.
Recently, standard and fluorescein laparoscopy has been used in cases of NEC 
when there is no evidence of perforation, but clinical deterioration with maximum 
support continues, and a diagnosis for the presence and extent of bowel necrosis 
needs to be made in order to decide against, or in favor of, surgical exploration and 
its type [47]. Laparoscopy can also identify infants who do not need surgical inter-
vention as it can visualize the viability and perfusion status of the bowel. According 
to a Cochrane review by Smith and Thyoka, which included eight reports and 44 
patients, laparoscopy was able to diagnose NEC in 91% of the cases and exclude in 
9% [48]. Moreover, additional surgical intervention was avoided in eight (18%) 
infants. Among those who did not require surgery, NEC was excluded in four (9%), 
while two (5%) had no perforation or intestinal gangrene, and two (5%) had NEC 
totalis which contraindicated surgery. Thirty-six infants out of 44 required surgery 
following laparoscopy, which included placement of a peritoneal drain (9) or a 
stoma (20) and intestinal resection and anastomosis (7). Perforation was detected 
in 25 out of 44 (57%) infants and was missed in one case which subsequently 
Figure 6. 
Flow chart outlining management principles in NEC.
Pediatric Surgery, Flowcharts and Clinical Algorithms
14
required laparotomy. Six (14%) infants died due to NEC totalis and two of ongoing 
and recurrent NEC following recovery from the acute episode of each. The authors 
concluded that laparoscopy is a useful procedure in the management of NEC, 
with one-fifth of patients not requiring further surgery. However, due to the lack 
of enough evidence about its utility and benefits, the procedure is generally not 
undertaken in the routine management of NEC.
9.3 Comparison of laparotomy and PPD
There are limited data about the superiority of one procedure over other. In a 
multicenter controlled study, 117 infants who were <34 weeks of gestation with 
perforated NEC were randomized to PPD or laparotomy. No differences were noted in 
mortality (34.5 versus 35.5%), TPN dependence on postoperative day 90 (47.2 versus 
40%), and length of hospital stay (126 ± 58 versus 116 ± 56 days) [49]. A subgroup 
analysis of cases with extensive pneumatosis intestinalis, GA less than 25 weeks, 
and serum pH less than 7.30 at presentation showed no significant advantage of one 
procedure over the other. In another randomized multicenter trial of 69 extremely 
low birth weight (ELBW) infants with NEC or SIP, no difference in the survival rates 
was noted between the two interventions, while 74% treated with PPD subsequently 
required laparotomy [50]. A cohort study from the NICHD neonatal research 
group reported no difference in mortality rate, and 24% treated with PPD required 
subsequent laparotomy. Blakely et al. reported that PPD is more likely to result in a 
composite outcome of death or neurodevelopmental impairment at 18–22 months 
postmenstrual age [51]. However in their study, PPD was performed in infants who 
were more premature (gestational age 24.7 versus 25.7 weeks), were more likely to be 
hypotensive, required higher respiratory support, and were more likely to have a pre-
operative diagnosis of SIP. Most of these studies are compromised by a lack pf power.
9.4 Post-surgery intestinal failure and short bowel syndrome
About 9% of NEC cases result in short bowel syndrome (SBS) with incidence 
inversely related to GA and almost 42% in intestinal failure and SBS [52, 53]. Such 
infants suffer from significant malabsorption and are at risk for sepsis, cholestasis, 
and liver failure due to prolonged parenteral nutrition (PN). It is suggested that 
infants with residual small bowel length ≤ 10% of expected small bowel length may 
develop SBS. The cumulative probability of weaning from PN by 24 months is 96% 
in infants with >50 cm of residual small bowel compared to 38% in those who have 
<50 cm of residual small bowel. Those with ≥41 cm of residual bowel are signifi-
cantly more likely to achieve enteral autonomy than those with less than 41 cm [53]. 
In general, those with post-resection length of remaining bowel less than 25% of 
the normal small bowel length have higher chances of developing SBS. The length 
of remaining bowel, however, is not the sole or best predictor of SBS. Infants at risk 
of SBS are as follows: parenteral antibiotics or mechanical ventilation on the day of 
onset of NEC, birth weight less than 750 g, enteral nutrition before the diagnosis 
of NEC, percentage of bowel resected, and placement and duration of a diverting 
jejunostomy. The intestines continue to grow after resection and contribute to the 
process of attaining enteral autonomy.
9.5 Surgical procedures for short bowel syndrome
In a NICHD cohort, 95% of cases of SBS were due to NEC with an overall inci-
dence of 0.7% of infants <1500 g at birth [52]. Approximately 42% of cases of NEC 
in infants <1500 g of BW who undergo surgery develop intestinal failure and SBS, 
15
Necrotizing Enterocolitis
DOI: http://dx.doi.org/10.5772/intechopen.85784
risk factors being lower birth weight, antibiotics use, positive pressure ventilation on 
the day of NEC, feeding, and lower post-resection length of remaining bowel [53]. 
Intestinal tailoring and lengthening procedure, also called “autologous intestinal 
reconstruction surgery” are performed in conditions where likelihood of weaning 
from PN is low despite rigorous intestinal rehabilitation measures. The criteria 
for surgery, tentative and not well supported by studies, include dilated small 
intestine, failure to attain intestinal autonomy, and absence of liver failure and GI 
dysmotility. The procedures aim at surgical lengthening of the bowel to increase 
the absorptive area and tapering or plicating the dilated bowel to improve motility. 
There is not enough literature on the subject to assess its clinical advantage. Bianchi 
procedure is a longitudinal intestinal lengthening and tailoring procedure (LILT) 
and may be successful in improving absorption and nutritional status but requires 
multiple anastomoses. Complications of this procedure include fistula formation, 
anastomotic stenosis, or leakage and sepsis [54]. The 6-year survival rate is 45%, and 
survivors have residual bowel length greater than 40 cm and no liver disease. The 
Bianchi procedure is not recommended in neonates with liver disease or intestine 
length less than 50 cm. The serial transverse enteroplasty procedure (STEP) is a 
substitute for LILT which increases the girth of bowel. It has a simpler technique that 
does not need bowel anastomoses, and the tapering can be performed on dilated 
bowel. STEP increases intestinal length, improves intestinal absorptive capacity, and 
may decrease the risk of D-lactic acidosis due to bacterial overgrowth. STEP is more 
favored over other techniques as the weaning from parenteral nutrition is faster and 
the need for later transplants lesser. There is no difference in early complications, 
growth rates, or survival between the two procedures, and nearly half of patients 
operated achieve enteral autonomy, with the median time to wean from parenteral 
nutrition (PN) being 21 months postoperatively. Patients whose bowel re-dilates 
after a lengthening procedure have worse overall outcomes. Complications of STEP 
include gastrointestinal bleeding, staple line leak, hematoma, abscess formation, 
stricture, pleural effusion, obstruction, a need for transplantation, and even death. 
In a recent publication, the rate of independence from PN post-STEP was reported 
as 58% with parenteral calories decreasing from 71 to 36% within 1 month and to 
12% after 1 year. The total increase in intestinal length achieved was about 49% [54].
Small bowel transplantation (SBT) may be considered in patients who have pro-
gressive, severe, or irreversible intestinal failure with associated liver disease. Other 
considerations might be a lack of venous access, recurrent life-threatening central 
venous catheter-associated sepsis, complete mesenteric thrombosis, slow growing 
tumors of the hepatic hilum or root of mesentery, or extremely short residual bowel 
with no chance of achieving enteral autonomy in patients who prefer transplanta-
tion over lifelong PN dependence [54]. Small bowel transplantation has a 5-year 
graft survival rate of 48% with lifelong immunosuppressant medications. Types of 
transplantation include isolated intestine, isolated liver, combined liver and intes-
tine, and multi-visceral. Complications are rejection, infection, graft-versus-host 
disease, and posttransplant lymphoproliferative disease. Overall, one year patient 
and intestine graft survival is 89%, being 79% in intestine and 72% in liver-intestine 
graft recipients. Patient and intestine graft survival falls to 46% by 10 years. At 10 
years the survival of intestine only recipients is 29%, whereas, that of liver-intestine 
recipients 39-42%. More recently, living donor intestinal transplantation has been 
done successfully in pediatric patients which eliminates waiting time.
9.6 Intestinal rehabilitation
This requires a multidisciplinary approach. The focus is on optimizing enteral 
feeding and weaning from PN with judicious use of pharmacotherapy and surgical 
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interventions. The approach is associated with improved survival and achievement 
of independence from PN.
10. Complications
The acute complications of NEC are sepsis, meningitis, peritonitis, intraabdomi-
nal abscess formation, DIC, thrombocytopenia, hypotension, shock, respiratory 
failure, metabolic or combined acidosis, hyponatremia, hyperglycemia, or less often 
hypoglycemia. Late complications are stricture formation, short bowel syndrome, 
and intestinal failure [55]. Rarely enterocele, enterocolic fistula, and intraabdomi-
nal abscess formation may be encountered. About 24% (95% CI 17–31%) of infants 
treated medically or surgically develop strictures in bowel which is unrelated to the 
severity of NEC or gestational age. The commonest location is in the colon, followed 
by the ileum and jejunum. Multiple sites strictures are seen. It can appear within 
2 to 3 months of the acute episode and as late as 20 months. Stricture may lead to 
local bacterial overgrowth resulting in repeated infections, bloody stools, failure to 
thrive, and symptoms of bowel obstruction. Strictures are more common following 
enterostomy; therefore contrast enemas should be performed 4–6 weeks after the 
occurrence of NEC and prior to surgical closure of enterostomy with reanastomosis 
or if and when feeding intolerance develops. Recurrent NEC may occur in 8% and 
adhesion ileus in 6% cases of NEC. Overall intestinal failure happens in 13% of all 
cases of NEC, inclusive of medically and surgically treated infants.
11. Long-term outcomes
Approximately half of all cases of NEC display no long-term sequelae. This 
includes cases of stage I NEC from Bell’s criteria. NEC is associated with significant 
impairment of growth and neurodevelopment [56–58]. Ten to thirteen percent 
of patients suffer from late gastrointestinal morbidity if resection is performed. 
Majority of infants who have had no extensive intestinal resection have normal 
gastrointestinal function at 1–10 years of age.
11.1 Growth and neurodevelopment
In a large multicenter study from the National Institute of Child Health and 
Human Development (NICHD) Neonatal Research Network, extremely low birth 
weight (ELBW) infants (BW <1000 g) who required surgical care were more 
likely to have significant growth delay and poorer developmental outcome at 
18–22 months compared with infants without NEC [56]. ELBW treated medically 
or surgically suffer from significant growth failure until 22 months, and in a lesser 
percentage beyond that age [57], while those who were medically treated do not 
differ in growth or developmental testing compared with those without NEC [58]. 
Infants with NEC are at increased risk for cerebral palsy and cognitive and severe 
visual impairment. At 7 years of age, survivors with NEC compared to controls 
demonstrate a higher rate of neurologic functional impairment.
11.2 Mortality
Overall survival in cases with NEC is 70–80%, being >95% in medical and 
70–75% in surgical NEC [59]. Lower BW and GA and surgical intervention, such 
as laparotomy and peritoneal drainage, are independent predictors for mortality. 
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Other risk factors associated with death from NEC are mechanical ventilation, 
treatment with vasopressor agents, surgical intervention, and black ethnicity as per 
a retrospective multicenter review of data [60]. Two thirds of NEC deaths occur 
within 7 days of diagnosis, with a median time of death being 1 day from the day of 
onset. Infants who die within 7 days of diagnosis have higher BW, and more often 
they are on vasopressors and high-frequency ventilation at the time of diagnosis. 
Risk factors for fulminant NEC, defined as death within 48 h of onset, are presence 
of portal venous air, increase in feeding volume by >20 mL/kg per day, HCT <22%, 
I/T ratio > 0.5, and total lymphocyte count <4000/μL as demonstrated in a multi-
center study [61].
11.3 Financial burden of NEC
The average total treatment cost of one case of NEC is US $500,000 [62, 63]. 
Total annual estimated cost of care of NEC in the United States is between $500 
million and $1 billion. Infants with NEC are hospitalized for 60 days longer than 
unaffected preterm infants if surgery is performed and >20 days longer if surgery 
is not required. Bowel resection—one of the most severe complications of NEC—is 
the major cause of short bowel syndrome in pediatric patients, making 95% of all 
such cases. The total mean cost of care over a 5-year period for a child with the short 
bowel syndrome has been estimated to be nearly $1.5 million.
12. Prevention
Prevention is the primary strategy in this devastating disease with undetermined 
etiology. Breast milk feeding, prolonging gestation to avoid prematurity, antenatal 
steroid, and the use of probiotics/prebiotics are established prevention strategies in 
NEC [16]. Nonaggressive feeding is evidenced to be efficacious. The rate of advance-
ment of feeding under 20 ml/kg/day is considered to be safe. Newer strategies, such 
as use of toll-like receptor agonist, glutamine, n-3 fatty acids, anti-cytokines, and 
growth factors are proposed preventive interventions, but most of these either lack 
evidence or have questionable safety. Compound CpG-DNA inhibit TLR4 signaling, 
thereby dramatically reducing the severity of NEC in mice. Clinically, the following 
measures are suggested to be practiced in order to reduce the risk of NEC: human 
milk (both mother’s and donor’s); standardized feeding guidelines, including 
early initiation with trophic feeds; the use of probiotics; antibiotic stewardship; 
optimization of enteral nutrition and growth; elimination of H2 blockers and acid 
pump suppressors; elimination of cow’s milk products; transfusion protocols; and 
transfusion outcome monitoring. Avoidance of hyperosmolar agents, treatment of 
polycythemia, and delayed cord clamping are other interventions that are suggested 
to be followed. Prophylactic probiotics, although not yet universally applied due 
to uncertainties about its dose and duration of therapy, have been documented to 
reduce the incidence of NEC, especially that of severe cases (RR 0.75 95% CI −0.57 to 
0.92) in infants <1500 g in multiple studies [64]. There are concerns about bactere-
mia and some aspects of quality control which restrict its use.
13. Future directions
NEC remains a major unsolved medical challenge for which no specific therapy 
exists. Recent research is concentrated on the role of TLR4 signaling within the 
intestinal epithelium and intestinal stem cells and modulation of the genetics and 
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intestinal microbiome. Fecal microbiota transplantation (FMT) has been shown to 
reverse the severity of experimental necrotizing enterocolitis (NEC) via oxidative 
stress modulation [65]. FMT decreases the extent of TLR4-mediated pro-inflamma-
tory signaling through TLR9 in the intestinal mucosa tissue. FMT also suppresses 
intestinal apoptosis and bacterial translocation across the intestinal barrier, which is 
accompanied by decreased inflammatory cytokine levels, altered bacterial micro-
biota, and regulated lymphocyte proportions. Research is needed to determine if 
the use of biomarkers along with specific clinical-biochemical indicators could lead 
to earlier intervention with modalities, such as peritoneal drainage or laparotomy 
that might decrease the severity of the disease process, thereby improving the 
long-term neurodevelopmental and growth outcomes. Improved care of short 
bowel syndrome with new surgical and medical approaches are additional subject 
for investigation. Tissue engineering techniques and techniques involving intestinal 
stem cells may represent unique, novel strategies for intestinal failure after severe 
NEC in the future.
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